From Fabrication to Function: Scalable Spray-Assisted Layer-by-Layer Films for Drug Delivery in Glaucoma
Authors:
- Alexandra M. L. OliveiraAlexandra M. L. Oliveira
- Maria RaposoMaria Raposo
- Sorawee YanwinitchaiSYSorawee Yanwinitchai
- Robert O. Williams IiiRobert O. Williams Iii
- Nykola C. JonesNJNykola C. Jones
- Søren V. HoffmannSHSøren V. Hoffmann
- Marta P. NascimentoMNMarta P. Nascimento
- Mafalda GuerreiroMGMafalda Guerreiro
- Diogo B. BitoqueDBDiogo B. Bitoque
- Luís Abegão PintoLPLuís Abegão Pinto
- Quirina FerreiraQFQuirina Ferreira
- Gabriela A. SilvaGSGabriela A. Silva
Preprint
- 14 August 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Glaucoma drainage device (GDD) surgery is frequently limited by postoperative fibro-blast proliferation, leading to device failure and the need for revision procedures. In this work, we developed a spray-assisted layer-by-layer (LbL) drug delivery system for GDD surfaces that enables localized release of antiproliferative agents, aiming to standardize patient care. Multilayer thin films composed of poly(β-amino ester) (PBAE) and a 5-fluorouracil (5-FU) and β-cyclodextrin (β-CD) complex (5-FU:β-CD) were fabricated, without (type A films) and with (type B films) graphene oxide (GO) barrier layers. Film growth was monitored by ultraviolet–visible spectroscopy (UV-Vis) and vacuum ultraviolet spectroscopy (VUV), confirming consistent, sequential deposition; type A films exhibited greater reproducibility than GO-containing type B films. Drug release studies revealed a rapid burst release within the first 5 min, fol-lowed by a plateau, regardless of GO incorporation. Cell cycle analysis confirmed that β-CD complexation preserved the biological activity of 5-FU, which induced an S-phase arrest in a dose-dependent manner. Although further optimization of film archi-tecture and composition is required to achieve sustained release, this study demon-strates the feasibility of spray-assisted LbL coatings as a localized drug delivery strate-gy for GDD surfaces. Overall, these findings establish a promising platform for the fu-ture development of more effective and standardized coatings for glaucoma surgical devices.Keywords
All Related Versions
This publication has 60 references indexed in Scilit:
- The Paul Glaucoma Implant: a systematic review of safety, efficacy, and emerging applicationsGraefe's Archive for Clinical and Experimental Ophthalmology, 2025
- In vitro release and cytotoxicity activity of 5-fluorouracil entrapped polycaprolactone nanoparticlesPolymer Bulletin, 2021
- Mitomycin C induced genotoxic stress in endothelial cells is associated with differential expression of proinflammatory cytokinesMutation Research - Genetic Toxicology and Environmental Mutagenesis, 2020
- A lab‐on‐a‐chip model of glaucomaBrain and Behavior, 2020
- Coating and Pharmacokinetic Evaluation of Air Spray Coated Drug Coated BalloonsCardiovascular Engineering and Technology, 2018
- Revision nach FiltrationschirurgieDer Ophthalmologe, 2016
- The Pathophysiology and Treatment of GlaucomaJAMA, 2014
- Functionalization of Amorphous SiO2 and 6H‐SiC(0001) Surfaces with Benzo[ghi]perylene‐1,2‐dicarboxylic Anhydride via an APTES LinkerSmall, 2012
- Understanding mechanisms of pressure-induced optic nerve damageProgress in Retinal and Eye Research, 2005
- Lens-induced glaucomaDocumenta Ophthalmologica, 1992